Methamphetamine Use and Affective Disorders

Current Status
Not Enrolled
Price
Free
Get Started

This on-demand course focuses on clinical presentations of methamphetamine use disorder and affective disorder comorbidity (e.g. depression, bipolar disorder).  Overlapping clinical symptoms across these disorders and  diagnostic considerations are discussed. Integrated treatment approaches for methamphetamine use and affective disorder comorbidity are reviewed, including off-label pharmacological treatment options for methamphetamine use disorder, evidence-based behavioral treatment approaches for methamphetamine use disorder, and pharmacological interventions for affective disorders. 

Launch Date: July 26, 2022

At the end of the on-demand course, participants will be able to:

  1. Recall at least two (2) short-term clinical effects of methamphetamine.
  2. Recognize at least two (2) overlapping clinical symptoms of methamphetamine use disorder and affective disorders.
  3. Identify at least three (3) pharmacological treatment approaches for affective disorder comorbidity.
  4. Specify at least two (2) evidence-based behavioral treatment approaches for methamphetamine use disorder.

Instructions for Continuing Education Credits

How to receive a CE/CME certificate:

For Continuing Medical Education (CME) for physicians, physician assistants, nurses, and nurse practitioners only, you will receive a link to complete the course evaluation for CME after watching the video for this course.

If you have any CME-related questions please contact Gloria Miele at gmiele@mednet.ucla.edu.

For other disciplines, you must pass the final test with a minimum of 80% correct. Once you pass the final test, you will be given links to complete a follow-up course evaluation. Choose the link that corresponds with the type of license you have. The link will take you to a course evaluation. Once you submit this required course evaluation, you will receive your CE or CME certificate via email within six to eight weeks.

If you have any CE-related questions please contact Darren Manley at dmanley@mednet.ucla.edu.

CME Statements:

Please view the linked CME LEARNER HANDOUT for more information about how to obtain CME credit.

The training course meets the qualifications for the provision of one and one (1.0) continuing medical education credit/contact hour (CME/CEH).

UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

UCLA ISAP designates this learning course for a maximum of one (1.0) AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

Continuing medical education credit will be awarded within 6-8 weeks following completion of the on-demand course.

This on-demand course meets the qualifications for the provision of one (1.0) continuing education credit/continuing medical education credit/contact hour (CEs/CME/CEH). 

UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content. 

UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for one (1.0) hour of continuing education credit for LMFTs, LCSWs, LPCCs, and LEPs, as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-21-339-1225), CATCs (ACCBC/CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151). 

CE credit will be awarded at the conclusion of the training. Upon completing the final module, you must pass the final test with a minimum of 80% correct. Once you pass the final test, it will display a link to complete a course evaluation and submit the required information for your CE certificate. Upon completing this required course evaluation, you will receive your CE certificate via email within six to eight weeks.

If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.

Estimated time to complete the course:

This course should take approximately 1.0 hour to complete.

Cost: Free

Disclosure statements:

Larissa Mooney, MD

None of the presenters, planners, or others in control of content for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Trainer:

Larissa Mooney, MD, UCLA ISAP, UCLA Division of Addiction Psychiatry

Recommended Audience:

This on-demand course is recommended for medical, behavioral health, and substance use disorder clinicians and administrative staff who are involved in providing multidisciplinary care to persons with stimulant and other substance use disorders, including, but not limited to:

  • Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Registered Nurses and LVNs
  • Psychologists
  • Marriage and Family Therapists
  • Social Workers
  • Alcohol and Other Drug and Mental Health Counselors
  • Case Managers
  • Medical Assistants

Instructions for Requesting Accommodations for Disability:

If you need a disability-related reasonable accommodation/alternative format for this event, please contact Darren Manley at dmanley@mednet.ucla.edu.

Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:

Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing: (UCLA ISAP, 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck). 

Please click on the lesson below to start the course.